HOME >> MEDICINE >> NEWS
'Smart' sunglasses and goggles let users adjust shade and color

Imagine a single pair of glasses with lenses that can be transparent or dark, and in shades of yellow, green or purple, all on command. A new lens with chameleon powers promises to dramatically improve sunglasses' function.

Shades that can be controlled at the touch of a button would interest athletes, construction workers and anyone with sensitive eyes. The glasses are made possible by a new material uniquely suited to the task: a low-cost sheet that changes color and shade using almost no power. Prototype "smart" glasses were presented today in Chicago at the American Chemical Society's 233rd national meeting.

"These lenses are more active, more intelligent, than today's sunglasses" said Chunye Xu, research assistant professor of mechanical engineering at the University of Washington. "But because of the materials we're using we don't think the price is going to be very different."

Motorcyclists, skiers or mountain bikers might be in the shade one moment and pop into bright sunlight an instant later. Some high-end sunglasses already let athletes adjust to such changing conditions by swapping out lenses. But the new shades, which take from one to two seconds to transition, allow a much quicker switch. Current lens choices don't simply include different levels of shading, but also different colors, such as yellow lenses, said to enhance contrasts and improve depth perception, or rose-colored glasses, which brighten low-light scenes. The new glasses would offer an endless range of options on one accessory.

Doctors already are recommending sunglasses that darken in response to the lighting conditions, known as photochromic lenses. These use incoming UV rays to trigger a chemical reaction that darkens the lens, but users can't adjust the shade. Also, the lenses may stay bright under strong midday light or get too dark in low-level evening light due to the angle of incoming rays. And photochromic lenses have the drawback tha
'"/>

Contact: Hannah Hickey
hickeyh@u.washington.edu
206-543-2580
University of Washington
27-Mar-2007


Page: 1 2 3

Related medicine news :

1. Smart mice teach scientists about learning process, brain disorders
2. Smart buildings to guide future first responders
3. Drugs users are increasingly more cautious with needles
4. Majority of herb users dont follow evidence-based indications, researchers find
5. Review finds ways of helping children of drug and alcohol misusers
6. New Inteleos features gives users the ability to tailor information
7. Statin users risk heart attacks by dropping treatment or taking low doses
8. Prescription opioids the predominant choice among illicit opioid users
9. Meth mouth can leave users toothless
10. NIDA announces recommendations to treat drug abusers, save money and reduce crime
11. Screening for Attention Deficit-Hyperactivity Disorder (ADHD) among substance users is improved

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Smart sunglasses and goggles let users adjust shade and color

(Date:6/19/2013)... Francisco, CA (PRWEB) June 19, 2013 ... accelerating throughout 2013 across all industries as cash rich ... Despite the differences across industries, all M&A transactions have ... rigorous due diligence to verify the history and quality ... carefully considered. , But when due diligence involves ...
(Date:6/18/2013)... 19, 2013 Consumer injury attorney Michael ... law firms have launched a new website for people ... dialysis. The website is http://www.DialysisLawsuitAttorneys.com . , "My ... begin offering legal services to people who may have ... NaturaLyte, or who may have suffered injuries due to ...
(Date:6/18/2013)... Exposed Skin Care has finally been released ... of all ages finally achieve the clear, beautiful skin they ... new acne clearing system combines the power of science and ... from forming. , After a quick review ... some of the most effective available on the market to ...
(Date:6/18/2013)... 2013 Parker Waichman LLP, a national ... injured by dangerous drugs and medical devices, has filed ... alleges that she was injured by transvaginal mesh ... in the U.S. District Court for the Southern District ... multidistrict litigation entitled In Re: American Medical Systems, Inc., ...
(Date:6/18/2013)... York, NY (PRWEB) June 18, 2013 Cheap ... tickets for the tournament which gets underway in July. ... savings on any CONCACAF ticket order. , The ... and cranny of the globe.    In fact, the hype of the ... Its popularity also trickled down the veins of fans ...
Breaking Medicine News(10 mins):Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 2Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 3Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 2Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 3Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 4Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 4Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 3
(Date:6/18/2013)... June 18, 2013  Decision Resources, one of ... pharmaceutical and healthcare issues, announces that its Market ... Middle East and ... the challenges and opportunities to gaining and maintaining ... comprising 24 countries. The countries covered by Market ...
(Date:6/18/2013)... New-generation electronic designs are focused on ... Simultaneously, circuitry is increasing the number of functions ... it performs at. Connecting cables from the active ... such as cameras or detectors, must be small, ... include custom cable designs for high-quality signal and ...
(Date:6/18/2013)... Australia And EMERYVILLE, Calif. ... Pharmaceuticals, Inc. presented final results today from a ... extended release) capsules demonstrating a statistically significant improvement ... from baseline at week 8 versus placebo in ... Adamas, investigational extended-release formulation of amantadine intended for ...
Breaking Medicine Technology:Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 2Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 3Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6
Cached News: